afternoon, Good everyone. Matt. Thanks,
with of meeting you I January month know, the As investor XXth. joined what expect, into the parts our the offering, exactly spent in technology, taking immediately and of about of more and you would our team, opportunities, deep you doing members a product first various some speaking on business. dive community, the learning MiMedx I associated
been far that the will potential I'm to expectations report it's would I surpassed have with job. I appreciated. significantly pleased only or What MiMedx in company has I is door. the the initially these not I Company had I the days month, been a I greater walking the great that While was taken I've a potential will knew at in the Today, learning see MiMedx. vast early unlock than the I believe outline is approach upside front
see streamline leadership I in is the plan. both approach financially strategically products tight growth roles, a disciplined and the and operationally profile. around always why add with has The we can't or Company's reason operations and In do this to from my strategic benefit been execution benefit is potential poised prior maximizing that to MiMedx. businesses no strong Company
the foundation tremendous efforts begin our and in state want to know place company, about a things have there considerable in also as tissue-based to we clinical that As knee create medtech I we today I journey, is great accomplish osteoarthritis. excitement unequivocally this value.
the world-class However, program OA wound EBITDA that commercially knee my is build is to focus a U.S. well substantial the near-term in before care generates business available
net solid an XX% XXXX generating QX, growth that year-over-year sales adjusted improving over we end, with a To finished and EBITDA.
business what in finish XXXX. we for revenue future. fourth Year. consistent This the since foreseeable already the place, fact, quarter strong I end can net momentum of given growth our believe, the top In were have us excellent has New ‘XX sales entering of deliver highest line our the with
the to what the business it times attracted about moving will by me I've thought specifics would addressing into several that and I surprisingly, been direction we then I Not dive question, about that will opportunity, our asked so was start forward. MiMedx
are there highlight While that most for me. compelling were this company, will many positive about I three the aspects
best-in-class with MiMedx The was difference field of the in Company's pioneer is of product number a positive the unmatched and placental of an the a increasing in an technology. first makes lives portfolio, biologics people.
abundantly succeed. as as quality to eager and with gotten knowledgeable new business and And the few difficulty]. prior we with experienced revenue important colleagues the I streamline it over clear my level of the at profitability. met stable the this to was was was joining significant Second a opportunities a organization. business it and people proud improve understand They have to MiMedx growth. team many as am that am of growing weeks, to large base, I or I has I've of for of to the operations know Company. is past to very people every opportunities that And finally, be [Technical me
our in this already fact Moreover, that company I work deals enhance or Some has opportunistic believe profile. that is make to growth ability will the of licensing underway. acquisitions
shift Let efforts organization. of are future the talk the gears the to about focusing me we and how
one Our determined three with resources accordingly. All of allocated these will company be execute well activity will growth stem by success on how being three basic we objectives. from areas,
while grow million a Surgical on Wound markets $XXX & first confident objective product enhancing are our approaching geographically. can we proper to profitable expanding position at of with highly double-digits growth portfolio, revenue, which leadership our build business we We in concurrently annually focus. Our the the by is operate
business. Wound business be on progress MiMedx to in order this invested for majority the call, such, reported core Company been our areas. have in & focus be our well last making the successful. On As of in and our execute resources we these Surgical We must will in
products in U.S. the to Specifically we new market. September, two introduced
quarter As will evident fast results new fourth are we to a these Pete start that make off our highlight, with products.
more already acceptance Additions and are products we market strengthen our our product areas widespread expand treated. cases to During into seen brand customer leading use are serve and the expectations. initial where portfolio market will our these months wounds these chronic acute the of have for relationships and to launch, early exceeding we our like
We establish have in to a done being of markets select outside also work on U.S. presence in in Japan the an reported the effort
also Gunze and product been initial in that We to the been bit been clearance Japan to get have we its hundred and progress. several While arduous, trained have have running use. up steady our started now a requirements Medical. have sales partner, our say we physicians reimbursement have for making with on generating I'm pleased recently and
OA our our opportunities knee active last markets product. development to engagement is is update, result team CRO, and way a to our we knee after you objective growth study all Thank exciting Medicine who the partner adjacent develop of is underway. This registrational a amount in the on work of those FDA of months, several Regenerative this second organization our OA milestone. over in announce Our to to tremendous with Nordic. By of addition pleased the us in the of to are of that now part got the
XXX observation be reminder, a file studies trial, this six expect for this that additional will BLA. and period us needed our is arms, order of As six-month in we patients monitoring. the In months approximately of enrollment to first two three of with a
pleased our on are progress as forward appropriate. be We to reporting underway look to and
the new it of for investment and largest also to being intent opportunities to OA Last is knee year's for Turn market, our our IP has into project that possible inorganically. the the is entry example. licensing in portfolio, our are additional Wound organically prime & While areas stayed Surgical complementary a look both a Therapeutics
will objective order ensure discipline process becomes to third our be control, rationalization growth profitable over more a corporate and to around expense finally, And improvement build continuous time. in our
Todd call, operating to objectives detailed his last our drive leverage. my predecessor On
and percentage get team sales to Specifically, and Wound was background the the we time improve corporate her new contribution establishing is human bring leadership has our Officer. in augment brings our to help the products least & extensive margin transform a short with and relatively yields of net step at Ricci Surgical Operating goals Whitlow disciplines to an improve market. XX%. the will the segment that in experience here XX% expenses team this as as important sales, segment tissue and Company to in Chief operations below way space process to production has the within An Ricci of to already
do companies those at success at establishing strategically we exactly process is That consistently growth prior identifying creating what drivers are that for by will on value had MiMedx. a most executing I've of business, then relevant. the the
to execute healthcare once companies we continue will If build to well the again, I our business, on the each areas. the but franchise, have only not of one value, the I of focused most areas believe create and regarded we in space, look in the tremendous in of three this stay reporting MiMedx to and our as establish opportunity highly market. leader on progress these forward in these
this sense what too share medics, you my my and Hopefully, hopefully to the gives you drew a excitement me future. for of
will turn Pete? fourth quarter who Now, let Pete, year call recap over full our to results. me and the
